This inventor holds 1 USPTO granted patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Satoshi Goda: Innovator in Hepatocellular Carcinoma Treatment
Introduction
Satoshi Goda is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medical research, particularly in the development of therapeutic agents for cancer treatment. His innovative work has led to the filing of a patent that addresses a critical health issue.
Latest Patents
Satoshi Goda holds a patent for a therapeutic agent aimed at treating hepatocellular carcinoma. The patent discloses a compound identified as 5-((2-(4-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof. This invention represents a promising advancement in cancer therapy.
Career Highlights
Goda is currently associated with Eisai R&D Management Co., Ltd., where he continues to engage in groundbreaking research. His work is characterized by a commitment to improving treatment options for patients suffering from serious illnesses.
Collaborations
Satoshi Goda collaborates with esteemed colleagues, including Atsumi Yamaguchi and Hajime Shimizu. These partnerships enhance the research environment and contribute to the development of innovative solutions in healthcare.
Conclusion
Satoshi Goda's contributions to the field of hepatocellular carcinoma treatment exemplify the impact of dedicated research and innovation. His patent and ongoing work at Eisai R&D Management Co., Ltd. highlight the importance of collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile